BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Protein Sciences Corporation Release: Tim Fields, VP Quality, Receives Ken Chapman Industry Recognition Award


10/25/2012 9:37:55 AM

MERIDEN, Conn., Oct. 24, 2012 /PRNewswire/ -- Protein Sciences announced that Tim Fields, Vice President of Quality, was named recipient of the Ken Chapman Industry Recognition Award during the International Validation Week Conference presented by the Institute of Validation Technology (IVT) on Oct. 23, 2012.

Ken Chapman who died of pancreatic cancer in 2006 was renowned for his forward-thinking approach to regulatory issues and best practices. Many of his ideas have become standard in industry. Tim was recognized for his continued contributions to the pharmaceutical and biopharmaceutical industries in compliance, quality, and validation.

Manon Cox, CEO, commented, "We are extremely proud that Tim is the recipient of this prestigious award. It is an important acknowledgement of his contributions in the field." She added, "Receiving the Ken Chapman award has special meaning to Tim as they worked together for almost 20 years and he learned to apply his practical approach to compliance and validation."

Tim joined Protein Sciences in 2010 as Director of Compliance and Training, and subsequently served as Senior Director of Quality Operations before becoming VP of Quality in 2011. He has more than 30 years of experience in the pharmaceutical industry, including more than 13 years at Pfizer and 16 years as a GMP compliance consultant. Tim has extensive experience in various areas of compliance, including quality systems, validation, aseptic processing, computerized system validation, GMP training, 21CFR Part 11, document management and auditing. He is a member of PDA and ISPE and is on the editorial review board for the Journal of Validation and Journal of GXP Compliance.

About Us

Protein Sciences Corporation is a vaccine development and protein production company based in Meriden, CT that is dedicated to saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals.

Our lead product, FluBlok, is a recombinant trivalent vaccine for seasonal influenza, consisting of recombinant influenza hemagglutinin (rHA) proteins that are manufactured using cell culture instead of eggs. FluBlok is highly purified, does not include thimerosal or antibiotics, and is low in endotoxins. FluBlok, which has shown exceptional performance in clinical trials, is under final review by the U.S. Food and Drug Administration.

Learn more at www.proteinsciences.com.

SOURCE Protein Sciences Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES